Dr Mark Petrie

  • Professor/Honorary Consultant, Honorary Clinical Associate Professor (Institute of Cardiovascular and Medical Sciences)

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • Palliative Care Needs in Patients with Heart Failure
    British Heart Foundation
    2013 - 2016
     

Publications

List by: Type | Date

Jump to: 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2001 | 2000 | 1999
Number of items: 84.

2016

Carrick, D. et al. (2016) Comparative prognostic utility of indices of microvascular function alone or in combination in patients with an acute ST-segment elevation myocardial infarction. Circulation, (doi:10.1161/CIRCULATIONAHA.116.022603) (PMID:27803036) (Early Online Publication)

Petrie, M. C. et al. (2016) Ten-year outcomes after coronary artery bypass grafting according to age in patients with heart failure and left ventricular systolic dysfunction: an analysis of the extended follow-up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure). Circulation, 134(18), pp. 1314-1324. (doi:10.1161/CIRCULATIONAHA.116.024800) (PMID:27573034)

Hennigan, B. et al. (2016) Discordance between resting and hyperemic indices of coronary stenosis severity: the VERIFY 2 study (a comparative study of resting coronary pressure gradient, instantaneous wave-free ratio and fractional flow reserve in an unselected population referred for invasive angiography). Circulation: Cardiovascular Interventions, 9(11), e004016. (doi:10.1161/CIRCINTERVENTIONS.116.004016) (PMID:27834663)

Hawkins, N. M. et al. (2016) Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment. European Journal of Heart Failure, 18(9), pp. 1162-1171. (doi:10.1002/ejhf.614) (PMID:27594177)

Rørth, R. et al. (2016) Return to the workforce following first hospitalization for heart failure: a Danish nationwide cohort study. Circulation, (doi:10.1161/CIRCULATIONAHA.116.021859) (PMID:27507406) (Early Online Publication)

Mangion, K. et al. (2016) Infarct size and left ventricular remodelling after preventive percutaneous coronary intervention. Heart, (doi:10.1136/heartjnl-2015-308660) (PMID:27504003) (Early Online Publication)

Carberry, J. et al. (2016) Remote zone extracellular volume and left ventricular remodeling in survivors of st-elevation myocardial infarction. Hypertension, 68(2), pp. 385-391. (doi:10.1161/HYPERTENSIONAHA.116.07222) (PMID:27354423) (PMCID:PMC4956675)

Docherty, K. F., Campbell, R. T., Jhund, P., Petrie, M. C., and McMurray, J. J.V. (2016) How robust are clinical trials in heart failure? European Heart Journal, (Accepted for Publication)

Carrick, D. et al. (2016) Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarction. JCI Insight, 1(6), e85768. (doi:10.1172/jci.insight.85768) (PMID:27699259) (PMCID:PMC5033815)

Campbell, R. T., Willox, G. P., Jhund, P. S., Hawkins, N. M., Huang, F., Petrie, M. C., and McMurray, J. J. V. (2016) Reporting of lost to follow-up and treatment discontinuation in device and pharmacotherapy trials in chronic heart failure: a systematic review. Circulation: Heart Failure, 9(5), e002842. (doi:10.1161/CIRCHEARTFAILURE.115.002842) (PMID:27162229)

Lee, M. M.Y. et al. (2016) Non-invasive versus invasive management in patients with prior coronary artery bypass surgery with a non-ST segment elevation acute coronary syndrome: study design of the pilot randomised controlled trial and registry (CABG-ACS). Open Heart, 3(1), e000371. (doi:10.1136/openhrt-2015-000371) (PMID:27110377) (PMCID:PMC4838768)

Abdul-Rahim, A. H., MacIsaac, R. L., Jhund, P. S., Petrie, M. C., Lees, K. R., and McMurray, J. J.V. (2016) Efficacy and safety of digoxin in patients with heart failure and reduced ejection fraction according to diabetes status: An analysis of the Digitalis Investigation Group (DIG) trial. International Journal of Cardiology, 209, pp. 310-316. (doi:10.1016/j.ijcard.2016.02.074) (PMID:26913372)

Carrick, D. et al. (2016) Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison to contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors. European Heart Journal, 37(13), pp. 1044-1059. (doi:10.1093/eurheartj/ehv372) (PMID:26261290)

Hasenfuß, G. et al. (2016) A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial. Lancet, 387(10025), pp. 1298-1304. (doi:10.1016/S0140-6736(16)00704-2) (PMID:27025436)

Carrick, D. et al. (2016) Temporal evolution of myocardial hemorrhage and edema in patients after acute ST-elevation myocardial infarction: pathophysiologic insights and clinical implications. Journal of the American Heart Association, 5, e002834. (doi:10.1161/JAHA.115.002834) (PMID:26908408) (PMCID:PMC4802451)

Ahmed, N. et al. (2016) Safety of guidewire-based measurement of fractional flow reserve and the index of microvascular resistance using intravenous adenosine in patients with acute or recent myocardial infarction. International Journal of Cardiology, 202, pp. 305-310. (doi:10.1016/j.ijcard.2015.09.014) (PMID:26418191) (PMCID:PMC4669307)

Carrick, D. et al. (2016) Myocardial hemorrhage after acute reperfused ST-segment-elevation myocardial infarction. Circulation: Cardiovascular Imaging, 9(1), e004148. (doi:10.1161/CIRCIMAGING.115.004148) (PMID:26763281) (PMCID:PMC4718183)

Jackson, C. E. et al. (2016) The incremental prognostic and clinical value of multiple novel biomarkers in heart failure. European Journal of Heart Failure, (doi:10.1002/ejhf.543) (PMID:27114189) (Early Online Publication)

2015

Nam, J. et al. (2015) Fractional flow reserve (FFR) versus angiography in guiding management to optimise outcomes in non-ST segment elevation myocardial infarction (FAMOUS-NSTEMI) developmental trial: cost-effectiveness using a mixed trial- and model-based methods. Cost Effectiveness and Resource Allocation, 2015(13), 19. (doi:10.1186/s12962-015-0045-9) (PMID:26578850) (PMCID:PMC4647286)

Jolicœur, E. M. et al. (2015) Importance of angina in patients with coronary disease, heart failure, and left ventricular systolic dysfunction. Journal of the American College of Cardiology, 66(19), pp. 2092-2100. (doi:10.1016/j.jacc.2015.08.882) (PMID:26541919)

Fisher, M., Petrie, M., Ambery, P., Donaldson, J., McMurray, J. J.V., and Ye, J. (2015) Cardiovascular safety of albiglutide in the Harmony programme: a meta-analysis. Lancet Diabetes and Endocrinology, 3(9), pp. 697-703. (doi:10.1016/s2213-8587(15)00233-8) (PMID:26276240)

Jackson, C. E. et al. (2015) Combined free light chains are novel predictors of prognosis in heart failure. JACC: Heart Failure, 3(8), pp. 618-625. (doi:10.1016/j.jchf.2015.03.014)

Rush, C. J., Campbell, R. T., Jhund, P. S., Connolly, E. C., Preiss, D., Gardner, R. S., Petrie, M. C., and McMurray, J. J.V. (2015) Falling cardiovascular mortality in heart failure with reduced ejection fraction and implications for clinical trials. JACC: Heart Failure, 3(8), pp. 603-614. (doi:10.1016/j.jchf.2015.03.013) (PMID:26251086)

Carrick, D. et al. (2015) Pathophysiology of LV remodeling in survivors of STEMI : inflammation, remote myocardium, and prognosis. JACC: Cardiovascular Imaging, 8(7), pp. 779-789. (doi:10.1016/j.jcmg.2015.03.007) (PMID:26093923) (PMCID:PMC4509710)

Petrie, M.C., Boyle, J.G., and McKay, G.A. (2015) Use of metformin in chronic kidney disease should continue to be based on common sense in the absence of an evidence base. Diabetic Medicine, 32(7), pp. 981-982. (doi:10.1111/dme.12709) (PMID:25645049)

Dalzell, J. R., Rocchiccioli, J. P., Weir, R. A.P., Jackson, C. E., Padmanabhan, N., Gardner, R. S., Petrie, M. C., and McMurray, J. J.V. (2015) The emerging potential of the apelin-APJ system in heart failure. Journal of Cardiac Failure, 21(6), pp. 489-498. (doi:10.1016/j.cardfail.2015.03.007) (PMID:25795508)

Campbell, R. T. et al. (2015) Palliative care needs in patients hospitalized with heart failure (PCHF) study: rationale and design. ESC Heart Failure, 2(1), pp. 25-36. (doi:10.1002/ehf2.12027)

Badar, A. A. et al. (2015) Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) programme. European Journal of Heart Failure, 17(2), pp. 196-204. (doi:10.1002/ejhf.221)

Badar, A. A. et al. (2015) Clinical characteristics and outcomes of patients with coronary artery disease and angina. Circulation: Heart Failure, 8(4), pp. 717-724. (doi:10.1161/CIRCHEARTFAILURE.114.002024) (PMID:26067854)

Carrick, D. et al. (2015) Pathophysiology of myocardial remodeling in survivors of ST-elevation myocardial infarction revealed by native T1 mapping: inflammation, remote myocardium and prognostic significance. Journal of Cardiovascular Magnetic Resonance, 17(Sup 1), Q:52. (doi:10.1186/1532-429X-17-S1-Q52) (PMCID:PMC4328295)

Carrick, D. et al. (2015) Prognostic significance of infarct core pathology in ST-elevation myocardial infarction survivors revealed by quantitative T2-weighted cardiac magnetic resonance. Journal of Cardiovascular Magnetic Resonance, 17(Sup 1), O54. (doi:10.1186/1532-429X-17-S1-O54) (PMCID:PMC4328590)

Carrick, D. et al. (2015) Prognostic significance of quantitative measures of myocardial infarct pathology using native T1 mapping, in survivors of ST-elevation myocardial infarction. Journal of Cardiovascular Magnetic Resonance, 17(Sup 1), O53. (doi:10.1186/1532-429X-17-S1-O53) (PMCID:PMC4328908)

Carrick, D. et al. (2015) Prognostic significance of infarct core pathology in ST-elevation myocardial infarction survivors revealed by non-contrast T1 mapping cardiac magnetic resonance. Journal of Cardiovascular Magnetic Resonance, 17(Sup 1), O26. (doi:10.1186/1532-429X-17-S1-O26) (PMCID:PMC4328668)

Layland, J. et al. (2015) Assessment of fractional flow reserve in patients with recent Non–ST-Segment–Elevation Myocardial Infarction. Circulation: Cardiovascular Interventions, 8(8), e002207. (doi:10.1161/circinterventions.114.002207) (PMID:26253733)

Mangion, K., Carrick, D., Payne, A., McClure, J., Mason, M., Petrie, M., McEntegart, M., Eteiba, H., Oldroyd, K., and Berry, C. (2015) Infarct burden following multivessel PCI vs. infarct-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study. Journal of Cardiovascular Magnetic Resonance, 17(Sup 1), O9. (doi:10.1186/1532-429X-17-S1-O9) (PMCID:PMC4328183)

Mangion, K., Carrick, D., Payne, A. R., McClure, J., Mason, M., Petrie, M., McEntegart, M., Eteiba, H., Oldroyd, K. G., and Berry, C. (2015) Left ventricular outcomes following multivessel PCI vs. infarct artery-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study. Journal of Cardiovascular Magnetic Resonance, 17(S1), P104. (doi:10.1186/1532-429X-17-S1-P104) (PMCID:PMC4328283)

2014

Badar, A. A. et al. (2014) Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). European Heart Journal, 35(48), pp. 3426-3433. (doi:10.1093/eurheartj/ehu342)

Wong, C.M. et al. (2014) Heart failure in younger patients: the Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). European Heart Journal, 35(39), pp. 2714-2721. (doi:10.1093/eurheartj/ehu216)

Carrick, D. et al. (2014) A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI). Journal of the American College of Cardiology, 63(20), pp. 2088-2098. (doi:10.1016/j.jacc.2014.02.530)

Al-Adhami, A., MacFie, A., Mathieson, C., Quasim, I., Smith, R., Craig, S., Gardner, R., Payne, J., Petrie, M., and Haj-Yahia, S. (2014) Ventricular assist devices as rescue therapy in cardiogenic shock after subarachnoid hemorrhage. Annals of Thoracic Surgery, 97(4), pp. 1440-1443. (doi:10.1016/j.athoracsur.2013.06.102) (PMID:24694427)

Sliwa, K. et al. (2014) EURObservational research programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM. European Journal of Heart Failure, 16(5), pp. 583-591. (doi:10.1002/ejhf.68)

Perez-Moreno, A. C. et al. (2014) Fatique as a predictor of outcome in patients with heart failure: analysis of CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure). JACC: Heart Failure, 2(2), pp. 187-197. (doi:10.1016/j.jchf.2014.01.001)

Dalzell, J. R., Seed, A., Berry, C., Whelan, C. J., Petrie, M. C., Padmanabhan, N., Clarke, A., Biggerstaff, F., Hillier, C., and McMurray, J. J.V. (2014) Effects of neutral endopeptidase (neprilysin) inhibition on the response to other vasoactive peptides in small human resistance arteries: studies with thiorphan and omapatrilat. Cardiovascular Therapeutics, 32(1), pp. 13-18. (doi:10.1111/1755-5922.12053) (PMID:24138103)

2013

Wong, C.M. et al. (2013) Clinical characteristics and outcomes of young and very young adults with heart failure: the CHARM programme. Journal of the American College of Cardiology, 62(20), pp. 1845-1854. (doi:10.1016/j.jacc.2013.05.072)

McGeoch, R.J. et al. (2013) Diagnostic utility of cardiac magnetic resonance imaging in STEMI survivors after emergency PCI. International Journal of Cardiology, 168(3), pp. 2933-2934. (doi:10.1016/j.ijcard.2013.03.179)

Carrick, D. et al. (2013) A randomised controlled trial of deferred stenting versus immediate stenting to prevent no-reflow in acute ST-elevation myocardial infarction. Scottish Medical Journal, 58(3), e41-e41. (doi:10.1177/0036933013495794)

Jackson, C.E. et al. (2013) Spectral microvolt T-wave alternans testing has no prognostic value in patients recently hospitalized with decompensated heart failure. European Journal of Heart Failure, 15(11), pp. 1253-1261. (doi:10.1093/eurjhf/hft085)

MacDonald, M.R., McMurray, J.J.V., and Petrie, M.C. (2013) Letter by MacDonald et al regarding article, "catheter ablation of atrial fibrillation". Circulation, 127(4), e433-e433. (doi:10.1161/CIRCULATIONAHA.112.137604)

2012

Campbell, R.T., Jhund, P.S., Castagno, D., Hawkins, N.M., Petrie, M.C., and McMurray, J.J.V. (2012) What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-Preserved, and I-PRESERVE? Journal of the American College of Cardiology, 60(23), pp. 2349-2356. (doi:10.1016/j.jacc.2012.04.064)

Pettit, S.J., Jhund, P.S., Hawkins, N.M., Gardner, R.S., Haj-Yahia, S., McMurray, J.J.V., and Petrie, M.C. (2012) How small is too small? A systematic review of center volume and outcome after cardiac transplantation. Circulation: Cardiovascular Quality and Outcomes, 5(6), pp. 783-790. (doi:10.1161/CIRCOUTCOMES.112.966630)

Castagno, D., Petrie, M.C., Claggett, B., and McMurray, J. (2012) Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failure. European Heart Journal, 33(9), pp. 1137-1141. (doi:10.1093/eurheartj/ehs004)

Castagno, D., Baird-Gunning, J., Jhund, P., Zoccai, G. B., MacDonald, M. R., Petrie, M., Gaita, F., and McMurray, J. (2012) Reply to the letter by Dr Erqou regarding "Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients". American Heart Journal, 163(5), e37. (doi:10.1016/j.ahj.2012.02.022)

MacDonald, M.R., McMurray, J.J.V., and Petrie, M.C. (2012) Catheter ablation for atrial fibrillation. New England Journal of Medicine, 366(11), p. 1060.

Jackson, C.E., Myles, R.C., Cobbe, S.M., Petrie, M.C., and McMurray, J.J.V. (2012) Microvolt T-wave alternans testing has no role at present in guiding therapy for patients at high risk of ventricular arrhythmias. Journal of the American College of Cardiology, 59(9), p. 856. (doi:10.1016/j.jacc.2011.10.897)

Jackson, C.E. et al. (2012) Microvolt T-wave alternans (MTWA) testing in 'real world' heart failure (HF): a study of prevalence and incremental prognostic value. Heart, 2012(98), A12. (doi:10.1136/heartjnl-2012-301877b.17)

Jackson, C.E. et al. (2012) Microvolt T-wave alternans testing should be used to guide arrhythmic therapy in heart failure patients: reply. European Journal of Heart Failure, 14(6), p. 678. (doi:10.1093/eurjhf/hfs077)

2011

Castagno, D., Baird-Gunning, J., Jhund, P.S., Biondi-Zoccai, G., MacDonald, M.R., Petrie, M.C., Gaita, F., and McMurray, J.J.V. (2011) Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: Evidence from a 37,229 patient meta-analysis. American Heart Journal, 162(5), 938-948.e2. (doi:10.1016/j.ahj.2011.07.030)

MacDonald, M. R. et al. (2011) Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial. Heart, 97(9), pp. 740-747. (doi:10.1136/hrt.2010.207340)

Velazquez, E.J. et al. (2011) Coronary-artery bypass surgery in patients with left ventricular dysfunction. New England Journal of Medicine, 364(17), pp. 1607-1616. (doi:10.1056/NEJMoa1100356)

2010

Hawkins, N.M., Jhund, P.S., Simpson, C.R., Petrie, M.C., MacDonald, M.R., Dunn, F.G., MacIntyre, K., and McMurray, J.J.V. (2010) Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland. European Journal of Heart Failure, 12(1), pp. 17-24. (doi:10.1093/eurjhf/hfp160)

MacDonald, M. R., Eurich, D. T., Majumdar, S. R., Lewsey, J. D., Bhagra, S., Jhund, P. S., Petrie, M. C., McMurray, J. J. V., Petrie, J.R., and McAlister, F. A. (2010) Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database. Diabetes Care, 33(6), pp. 1213-1218. (doi:10.2337/dc09-2227)

Shah, A. M. et al. (2010) The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction. European Journal of Heart Failure, 12(11), pp. 1229-1237. (doi:10.1093/eurjhf/hfq179)

2009

Hawkins, N. M., Petrie, M. C., Jhund, P. S., Chalmers, G. W., Dunn, F. G., and McMurray, J. J.V. (2009) Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. European Journal of Heart Failure, 11(2), pp. 130-139. (doi:10.1093/eurjhf/hfn013)

Hawkins, N.M., MacDonald, M.R., Petrie, M.C., Chalmers, G., Carter, R., Dunn, F.G., and McMurray, J.J. (2009) Bisoprolol in patients with heart failure and moderate to severe chronic obstructive pulmonary disease: a randomized controlled trial. European Journal of Heart Failure, 11(7), pp. 684-690. (doi:10.1093/eurjhf/hfp066)

Jackson, C.E., Dalzell, J.R., Bezlyak, V., Tsorlalis, I.K., Myles, R.C., Spooner, R., Ford, I., Petrie, M.C., Cobbe, S., and McMurray, J.J. (2009) Red cell distribution width has incremental prognostic value to B-type natriuretic peptide in acute heart failure. European Journal of Heart Failure, 11(12), pp. 1152-1154. (doi:10.1093/eurjhf/hfp157)

MacDonald, M.R., Petrie, M.C., Fisher, M., and McMurray, J.J.V. (2009) Pharmacologic management of patients with both heart failure and diabetes. Current Heart Failure Reports, 6(2), pp. 126-132. (doi:10.1007/s11897-009-0019-3)

Stanton, T., Hawkins, N. M., Hogg, K. J., Goodfield, N. E.R., Petrie, M. C., and McMurray, J. J.V. (2009) Three-dimensional echocardiography for optimization of cardiac resynchronization therapy: reply. European Heart Journal, 30(4), pp. 505-506. (doi:10.1093/eurheartj/ehp002)

2008

MacDonald, M.R. et al. (2008) Discordant short- and long-term outcomes associated with diabetes in patients with heart failure: importance of age and sex: a population study of 5.1 million people in Scotland. Circulation: Heart Failure, 1(4), pp. 234-241. (doi:10.1161/CIRCHEARTFAILURE.108.794008)

MacDonald, M.R., Petrie, M.C., Hawkins, N.M., Petrie, J.R., Fisher, M., McKelvie, R., Aguilar, D., Krum, H., and McMurray, J.J.V. (2008) Diabetes, left ventricular systolic dysfunction, and chronic heart failure. European Heart Journal, 29(10), pp. 1224-1240. (doi:10.1093/eurheartj/ehn156)

MacDonald, M.R. et al. (2008) Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. European Heart Journal, 29(11), pp. 1377-1385. (doi:10.1093/eurheartj/ehn153)

Stanton, T., Hawkins, N.M., Hogg, K.J., Goodfield, N.E.R., Petrie, M.C., and McMurray, J.J.V. (2008) How should we optimize cardiac resynchronization therapy? European Heart Journal, 29(20), pp. 2458-2472. (doi:10.1093/eurheartj/ehn380)

2007

Petrie, M. C., and McMurray, J. J.V. (2007) Dysglycemia and heart failure hospitalization: what is the link? Circulation, 115(11), pp. 1334-1335. (doi:10.1161/circulationaha.106.685214) (PMID:17372185)

MacDonald, M. R., Petrie, M. C., Hawkins, N. M., and McMurray, J. J. (2007) Diabetes, left ventricular systolic dysfunction and chronic heart failure. In: Fisher, M. and McMurray, J. J. (eds.) Diabetic Cardiology. Series: Diabetes in practice. John Wiley & Sons, Ltd.: Chichester, pp. 93-134. ISBN 9780470862049 (doi:10.1002/9780470723807.ch4)

2006

MacDonald, M. R., Hawkins, N. M., McMurray, J. J.V., Dargie, H. J., and Petrie, M. C. (2006) Is CHARM-added candesartan tolerated in 'real-life” patients with advanced chronic heart failure? Journal of Cardiac Failure, 12(6), S126. (doi:10.1016/j.cardfail.2006.06.434)

Cobbe, S., Martin, W., Motherwell, D., and Petrie, M. (2006) I-123-Metaiodobenzylguanidine in chronic heart failure: is there a clinical use? Nuclear Medicine Communications, 27(12), pp. 927-931. (doi:10.1097/01.mnm.0000251331.48203.74)

2005

Petrie, M. C., McClure, S. J., Love, M. P., and McMurray, J. J.V. (2005) Novel neuropeptides in the pathophysiology of heart failure: adrenomedullin and endothelin-1. European Journal of Heart Failure, 1(1), pp. 25-29. (doi:10.1016/s1388-9842(98)00013-0) (PMID:10937975)

2001

Blue, L. et al. (2001) Randomised controlled trial of specialist nurse intervention in heart failure. British Medical Journal, 323, pp. 715-718. (doi:10.1136/bmj.323.7315.715)

McDonald, J. E., Padmanabhan, N., Petrie, M. C., Hillier, C., Connell, J. M.C., and McMurray, J. J.V. (2001) Vasoconstrictor Effect of the Angiotensin-Converting Enzyme-Resistant, Chymase-Specific Substrate [Pro11D-Ala12] Angiotensin I in Human Dorsal Hand Veins: In Vivo Demonstration of Non-ACE Production of Angiotensin II in Humans. Circulation, 104(15), pp. 1805-1808. (doi:10.1161/hc4001.097220) (PMID:11591618)

Petrie, M., McDonald, J., Hillier, C., Morton, J., and McMurray, J. (2001) Effects of adrenomedullin on angiotensin II stimulated atrial natriuretic peptide and arginine vasopressin secretion in healthy humans. British Journal of Clinical Pharmacology, 52(2), pp. 165-168. (doi:10.1046/j.0306-5251.2001.01428.x)

Petrie, M., Padmanabhan, N., McDonald, J., Hillier, C., Connell, J., and McMurray, J. (2001) Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease. Journal of the American College of Cardiology, 37(4), pp. 1056-1061. (doi:10.1016/S0735-1097(01)01111-1)

2000

Shah, M. R. et al. (2000) Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registry. American Journal of Medicine, 109(6), pp. 489-492. (doi:10.1016/s0002-9343(00)00529-5) (PMID:11042239)

Caruana, L., Petrie, M.C., Davie, A.P., and McMurray, J. (2000) Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study. British Medical Journal, 321, pp. 215-218. (doi:10.1136/bmj.321.7255.215)

Petrie, M. C., Hillier, C., Morton, J., and McMurray, J. J.V. (2000) Adrenomedullin selectively inhibits angiotensin II-induced aldosterone secretion in humans. Journal of Hypertension, 18(1), pp. 61-64. (doi:10.1097/00004872-200018010-00009) (PMID:10678544)

1999

Darnley, G. M., Gray, A. C., McClure, S. J., Neary, P., Petrie, M., McMurray, J. J.V., and MacFarlane, N. G. (1999) Effects of resistive breathing on exercise capacity and diaphragm function in patients with ischaemic heart disease. European Journal of Heart Failure, 1(3), pp. 297-300. (doi:10.1016/s1388-9842(99)00027-6) (PMID:10935679)

This list was generated on Wed Dec 7 12:20:21 2016 GMT.
Number of items: 84.

Articles

Carrick, D. et al. (2016) Comparative prognostic utility of indices of microvascular function alone or in combination in patients with an acute ST-segment elevation myocardial infarction. Circulation, (doi:10.1161/CIRCULATIONAHA.116.022603) (PMID:27803036) (Early Online Publication)

Petrie, M. C. et al. (2016) Ten-year outcomes after coronary artery bypass grafting according to age in patients with heart failure and left ventricular systolic dysfunction: an analysis of the extended follow-up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure). Circulation, 134(18), pp. 1314-1324. (doi:10.1161/CIRCULATIONAHA.116.024800) (PMID:27573034)

Hennigan, B. et al. (2016) Discordance between resting and hyperemic indices of coronary stenosis severity: the VERIFY 2 study (a comparative study of resting coronary pressure gradient, instantaneous wave-free ratio and fractional flow reserve in an unselected population referred for invasive angiography). Circulation: Cardiovascular Interventions, 9(11), e004016. (doi:10.1161/CIRCINTERVENTIONS.116.004016) (PMID:27834663)

Hawkins, N. M. et al. (2016) Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment. European Journal of Heart Failure, 18(9), pp. 1162-1171. (doi:10.1002/ejhf.614) (PMID:27594177)

Rørth, R. et al. (2016) Return to the workforce following first hospitalization for heart failure: a Danish nationwide cohort study. Circulation, (doi:10.1161/CIRCULATIONAHA.116.021859) (PMID:27507406) (Early Online Publication)

Mangion, K. et al. (2016) Infarct size and left ventricular remodelling after preventive percutaneous coronary intervention. Heart, (doi:10.1136/heartjnl-2015-308660) (PMID:27504003) (Early Online Publication)

Carberry, J. et al. (2016) Remote zone extracellular volume and left ventricular remodeling in survivors of st-elevation myocardial infarction. Hypertension, 68(2), pp. 385-391. (doi:10.1161/HYPERTENSIONAHA.116.07222) (PMID:27354423) (PMCID:PMC4956675)

Docherty, K. F., Campbell, R. T., Jhund, P., Petrie, M. C., and McMurray, J. J.V. (2016) How robust are clinical trials in heart failure? European Heart Journal, (Accepted for Publication)

Carrick, D. et al. (2016) Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarction. JCI Insight, 1(6), e85768. (doi:10.1172/jci.insight.85768) (PMID:27699259) (PMCID:PMC5033815)

Campbell, R. T., Willox, G. P., Jhund, P. S., Hawkins, N. M., Huang, F., Petrie, M. C., and McMurray, J. J. V. (2016) Reporting of lost to follow-up and treatment discontinuation in device and pharmacotherapy trials in chronic heart failure: a systematic review. Circulation: Heart Failure, 9(5), e002842. (doi:10.1161/CIRCHEARTFAILURE.115.002842) (PMID:27162229)

Lee, M. M.Y. et al. (2016) Non-invasive versus invasive management in patients with prior coronary artery bypass surgery with a non-ST segment elevation acute coronary syndrome: study design of the pilot randomised controlled trial and registry (CABG-ACS). Open Heart, 3(1), e000371. (doi:10.1136/openhrt-2015-000371) (PMID:27110377) (PMCID:PMC4838768)

Abdul-Rahim, A. H., MacIsaac, R. L., Jhund, P. S., Petrie, M. C., Lees, K. R., and McMurray, J. J.V. (2016) Efficacy and safety of digoxin in patients with heart failure and reduced ejection fraction according to diabetes status: An analysis of the Digitalis Investigation Group (DIG) trial. International Journal of Cardiology, 209, pp. 310-316. (doi:10.1016/j.ijcard.2016.02.074) (PMID:26913372)

Carrick, D. et al. (2016) Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison to contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors. European Heart Journal, 37(13), pp. 1044-1059. (doi:10.1093/eurheartj/ehv372) (PMID:26261290)

Hasenfuß, G. et al. (2016) A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial. Lancet, 387(10025), pp. 1298-1304. (doi:10.1016/S0140-6736(16)00704-2) (PMID:27025436)

Carrick, D. et al. (2016) Temporal evolution of myocardial hemorrhage and edema in patients after acute ST-elevation myocardial infarction: pathophysiologic insights and clinical implications. Journal of the American Heart Association, 5, e002834. (doi:10.1161/JAHA.115.002834) (PMID:26908408) (PMCID:PMC4802451)

Ahmed, N. et al. (2016) Safety of guidewire-based measurement of fractional flow reserve and the index of microvascular resistance using intravenous adenosine in patients with acute or recent myocardial infarction. International Journal of Cardiology, 202, pp. 305-310. (doi:10.1016/j.ijcard.2015.09.014) (PMID:26418191) (PMCID:PMC4669307)

Carrick, D. et al. (2016) Myocardial hemorrhage after acute reperfused ST-segment-elevation myocardial infarction. Circulation: Cardiovascular Imaging, 9(1), e004148. (doi:10.1161/CIRCIMAGING.115.004148) (PMID:26763281) (PMCID:PMC4718183)

Jackson, C. E. et al. (2016) The incremental prognostic and clinical value of multiple novel biomarkers in heart failure. European Journal of Heart Failure, (doi:10.1002/ejhf.543) (PMID:27114189) (Early Online Publication)

Nam, J. et al. (2015) Fractional flow reserve (FFR) versus angiography in guiding management to optimise outcomes in non-ST segment elevation myocardial infarction (FAMOUS-NSTEMI) developmental trial: cost-effectiveness using a mixed trial- and model-based methods. Cost Effectiveness and Resource Allocation, 2015(13), 19. (doi:10.1186/s12962-015-0045-9) (PMID:26578850) (PMCID:PMC4647286)

Jolicœur, E. M. et al. (2015) Importance of angina in patients with coronary disease, heart failure, and left ventricular systolic dysfunction. Journal of the American College of Cardiology, 66(19), pp. 2092-2100. (doi:10.1016/j.jacc.2015.08.882) (PMID:26541919)

Fisher, M., Petrie, M., Ambery, P., Donaldson, J., McMurray, J. J.V., and Ye, J. (2015) Cardiovascular safety of albiglutide in the Harmony programme: a meta-analysis. Lancet Diabetes and Endocrinology, 3(9), pp. 697-703. (doi:10.1016/s2213-8587(15)00233-8) (PMID:26276240)

Jackson, C. E. et al. (2015) Combined free light chains are novel predictors of prognosis in heart failure. JACC: Heart Failure, 3(8), pp. 618-625. (doi:10.1016/j.jchf.2015.03.014)

Rush, C. J., Campbell, R. T., Jhund, P. S., Connolly, E. C., Preiss, D., Gardner, R. S., Petrie, M. C., and McMurray, J. J.V. (2015) Falling cardiovascular mortality in heart failure with reduced ejection fraction and implications for clinical trials. JACC: Heart Failure, 3(8), pp. 603-614. (doi:10.1016/j.jchf.2015.03.013) (PMID:26251086)

Carrick, D. et al. (2015) Pathophysiology of LV remodeling in survivors of STEMI : inflammation, remote myocardium, and prognosis. JACC: Cardiovascular Imaging, 8(7), pp. 779-789. (doi:10.1016/j.jcmg.2015.03.007) (PMID:26093923) (PMCID:PMC4509710)

Petrie, M.C., Boyle, J.G., and McKay, G.A. (2015) Use of metformin in chronic kidney disease should continue to be based on common sense in the absence of an evidence base. Diabetic Medicine, 32(7), pp. 981-982. (doi:10.1111/dme.12709) (PMID:25645049)

Dalzell, J. R., Rocchiccioli, J. P., Weir, R. A.P., Jackson, C. E., Padmanabhan, N., Gardner, R. S., Petrie, M. C., and McMurray, J. J.V. (2015) The emerging potential of the apelin-APJ system in heart failure. Journal of Cardiac Failure, 21(6), pp. 489-498. (doi:10.1016/j.cardfail.2015.03.007) (PMID:25795508)

Campbell, R. T. et al. (2015) Palliative care needs in patients hospitalized with heart failure (PCHF) study: rationale and design. ESC Heart Failure, 2(1), pp. 25-36. (doi:10.1002/ehf2.12027)

Badar, A. A. et al. (2015) Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) programme. European Journal of Heart Failure, 17(2), pp. 196-204. (doi:10.1002/ejhf.221)

Badar, A. A. et al. (2015) Clinical characteristics and outcomes of patients with coronary artery disease and angina. Circulation: Heart Failure, 8(4), pp. 717-724. (doi:10.1161/CIRCHEARTFAILURE.114.002024) (PMID:26067854)

Carrick, D. et al. (2015) Pathophysiology of myocardial remodeling in survivors of ST-elevation myocardial infarction revealed by native T1 mapping: inflammation, remote myocardium and prognostic significance. Journal of Cardiovascular Magnetic Resonance, 17(Sup 1), Q:52. (doi:10.1186/1532-429X-17-S1-Q52) (PMCID:PMC4328295)

Carrick, D. et al. (2015) Prognostic significance of infarct core pathology in ST-elevation myocardial infarction survivors revealed by quantitative T2-weighted cardiac magnetic resonance. Journal of Cardiovascular Magnetic Resonance, 17(Sup 1), O54. (doi:10.1186/1532-429X-17-S1-O54) (PMCID:PMC4328590)

Carrick, D. et al. (2015) Prognostic significance of quantitative measures of myocardial infarct pathology using native T1 mapping, in survivors of ST-elevation myocardial infarction. Journal of Cardiovascular Magnetic Resonance, 17(Sup 1), O53. (doi:10.1186/1532-429X-17-S1-O53) (PMCID:PMC4328908)

Carrick, D. et al. (2015) Prognostic significance of infarct core pathology in ST-elevation myocardial infarction survivors revealed by non-contrast T1 mapping cardiac magnetic resonance. Journal of Cardiovascular Magnetic Resonance, 17(Sup 1), O26. (doi:10.1186/1532-429X-17-S1-O26) (PMCID:PMC4328668)

Layland, J. et al. (2015) Assessment of fractional flow reserve in patients with recent Non–ST-Segment–Elevation Myocardial Infarction. Circulation: Cardiovascular Interventions, 8(8), e002207. (doi:10.1161/circinterventions.114.002207) (PMID:26253733)

Mangion, K., Carrick, D., Payne, A., McClure, J., Mason, M., Petrie, M., McEntegart, M., Eteiba, H., Oldroyd, K., and Berry, C. (2015) Infarct burden following multivessel PCI vs. infarct-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study. Journal of Cardiovascular Magnetic Resonance, 17(Sup 1), O9. (doi:10.1186/1532-429X-17-S1-O9) (PMCID:PMC4328183)

Mangion, K., Carrick, D., Payne, A. R., McClure, J., Mason, M., Petrie, M., McEntegart, M., Eteiba, H., Oldroyd, K. G., and Berry, C. (2015) Left ventricular outcomes following multivessel PCI vs. infarct artery-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study. Journal of Cardiovascular Magnetic Resonance, 17(S1), P104. (doi:10.1186/1532-429X-17-S1-P104) (PMCID:PMC4328283)

Badar, A. A. et al. (2014) Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). European Heart Journal, 35(48), pp. 3426-3433. (doi:10.1093/eurheartj/ehu342)

Wong, C.M. et al. (2014) Heart failure in younger patients: the Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). European Heart Journal, 35(39), pp. 2714-2721. (doi:10.1093/eurheartj/ehu216)

Carrick, D. et al. (2014) A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI). Journal of the American College of Cardiology, 63(20), pp. 2088-2098. (doi:10.1016/j.jacc.2014.02.530)

Al-Adhami, A., MacFie, A., Mathieson, C., Quasim, I., Smith, R., Craig, S., Gardner, R., Payne, J., Petrie, M., and Haj-Yahia, S. (2014) Ventricular assist devices as rescue therapy in cardiogenic shock after subarachnoid hemorrhage. Annals of Thoracic Surgery, 97(4), pp. 1440-1443. (doi:10.1016/j.athoracsur.2013.06.102) (PMID:24694427)

Sliwa, K. et al. (2014) EURObservational research programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM. European Journal of Heart Failure, 16(5), pp. 583-591. (doi:10.1002/ejhf.68)

Perez-Moreno, A. C. et al. (2014) Fatique as a predictor of outcome in patients with heart failure: analysis of CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure). JACC: Heart Failure, 2(2), pp. 187-197. (doi:10.1016/j.jchf.2014.01.001)

Dalzell, J. R., Seed, A., Berry, C., Whelan, C. J., Petrie, M. C., Padmanabhan, N., Clarke, A., Biggerstaff, F., Hillier, C., and McMurray, J. J.V. (2014) Effects of neutral endopeptidase (neprilysin) inhibition on the response to other vasoactive peptides in small human resistance arteries: studies with thiorphan and omapatrilat. Cardiovascular Therapeutics, 32(1), pp. 13-18. (doi:10.1111/1755-5922.12053) (PMID:24138103)

Wong, C.M. et al. (2013) Clinical characteristics and outcomes of young and very young adults with heart failure: the CHARM programme. Journal of the American College of Cardiology, 62(20), pp. 1845-1854. (doi:10.1016/j.jacc.2013.05.072)

McGeoch, R.J. et al. (2013) Diagnostic utility of cardiac magnetic resonance imaging in STEMI survivors after emergency PCI. International Journal of Cardiology, 168(3), pp. 2933-2934. (doi:10.1016/j.ijcard.2013.03.179)

Carrick, D. et al. (2013) A randomised controlled trial of deferred stenting versus immediate stenting to prevent no-reflow in acute ST-elevation myocardial infarction. Scottish Medical Journal, 58(3), e41-e41. (doi:10.1177/0036933013495794)

Jackson, C.E. et al. (2013) Spectral microvolt T-wave alternans testing has no prognostic value in patients recently hospitalized with decompensated heart failure. European Journal of Heart Failure, 15(11), pp. 1253-1261. (doi:10.1093/eurjhf/hft085)

MacDonald, M.R., McMurray, J.J.V., and Petrie, M.C. (2013) Letter by MacDonald et al regarding article, "catheter ablation of atrial fibrillation". Circulation, 127(4), e433-e433. (doi:10.1161/CIRCULATIONAHA.112.137604)

Campbell, R.T., Jhund, P.S., Castagno, D., Hawkins, N.M., Petrie, M.C., and McMurray, J.J.V. (2012) What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-Preserved, and I-PRESERVE? Journal of the American College of Cardiology, 60(23), pp. 2349-2356. (doi:10.1016/j.jacc.2012.04.064)

Pettit, S.J., Jhund, P.S., Hawkins, N.M., Gardner, R.S., Haj-Yahia, S., McMurray, J.J.V., and Petrie, M.C. (2012) How small is too small? A systematic review of center volume and outcome after cardiac transplantation. Circulation: Cardiovascular Quality and Outcomes, 5(6), pp. 783-790. (doi:10.1161/CIRCOUTCOMES.112.966630)

Castagno, D., Petrie, M.C., Claggett, B., and McMurray, J. (2012) Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failure. European Heart Journal, 33(9), pp. 1137-1141. (doi:10.1093/eurheartj/ehs004)

Castagno, D., Baird-Gunning, J., Jhund, P., Zoccai, G. B., MacDonald, M. R., Petrie, M., Gaita, F., and McMurray, J. (2012) Reply to the letter by Dr Erqou regarding "Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients". American Heart Journal, 163(5), e37. (doi:10.1016/j.ahj.2012.02.022)

MacDonald, M.R., McMurray, J.J.V., and Petrie, M.C. (2012) Catheter ablation for atrial fibrillation. New England Journal of Medicine, 366(11), p. 1060.

Jackson, C.E., Myles, R.C., Cobbe, S.M., Petrie, M.C., and McMurray, J.J.V. (2012) Microvolt T-wave alternans testing has no role at present in guiding therapy for patients at high risk of ventricular arrhythmias. Journal of the American College of Cardiology, 59(9), p. 856. (doi:10.1016/j.jacc.2011.10.897)

Jackson, C.E. et al. (2012) Microvolt T-wave alternans (MTWA) testing in 'real world' heart failure (HF): a study of prevalence and incremental prognostic value. Heart, 2012(98), A12. (doi:10.1136/heartjnl-2012-301877b.17)

Jackson, C.E. et al. (2012) Microvolt T-wave alternans testing should be used to guide arrhythmic therapy in heart failure patients: reply. European Journal of Heart Failure, 14(6), p. 678. (doi:10.1093/eurjhf/hfs077)

Castagno, D., Baird-Gunning, J., Jhund, P.S., Biondi-Zoccai, G., MacDonald, M.R., Petrie, M.C., Gaita, F., and McMurray, J.J.V. (2011) Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: Evidence from a 37,229 patient meta-analysis. American Heart Journal, 162(5), 938-948.e2. (doi:10.1016/j.ahj.2011.07.030)

MacDonald, M. R. et al. (2011) Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial. Heart, 97(9), pp. 740-747. (doi:10.1136/hrt.2010.207340)

Velazquez, E.J. et al. (2011) Coronary-artery bypass surgery in patients with left ventricular dysfunction. New England Journal of Medicine, 364(17), pp. 1607-1616. (doi:10.1056/NEJMoa1100356)

Hawkins, N.M., Jhund, P.S., Simpson, C.R., Petrie, M.C., MacDonald, M.R., Dunn, F.G., MacIntyre, K., and McMurray, J.J.V. (2010) Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland. European Journal of Heart Failure, 12(1), pp. 17-24. (doi:10.1093/eurjhf/hfp160)

MacDonald, M. R., Eurich, D. T., Majumdar, S. R., Lewsey, J. D., Bhagra, S., Jhund, P. S., Petrie, M. C., McMurray, J. J. V., Petrie, J.R., and McAlister, F. A. (2010) Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database. Diabetes Care, 33(6), pp. 1213-1218. (doi:10.2337/dc09-2227)

Shah, A. M. et al. (2010) The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction. European Journal of Heart Failure, 12(11), pp. 1229-1237. (doi:10.1093/eurjhf/hfq179)

Hawkins, N. M., Petrie, M. C., Jhund, P. S., Chalmers, G. W., Dunn, F. G., and McMurray, J. J.V. (2009) Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. European Journal of Heart Failure, 11(2), pp. 130-139. (doi:10.1093/eurjhf/hfn013)

Hawkins, N.M., MacDonald, M.R., Petrie, M.C., Chalmers, G., Carter, R., Dunn, F.G., and McMurray, J.J. (2009) Bisoprolol in patients with heart failure and moderate to severe chronic obstructive pulmonary disease: a randomized controlled trial. European Journal of Heart Failure, 11(7), pp. 684-690. (doi:10.1093/eurjhf/hfp066)

Jackson, C.E., Dalzell, J.R., Bezlyak, V., Tsorlalis, I.K., Myles, R.C., Spooner, R., Ford, I., Petrie, M.C., Cobbe, S., and McMurray, J.J. (2009) Red cell distribution width has incremental prognostic value to B-type natriuretic peptide in acute heart failure. European Journal of Heart Failure, 11(12), pp. 1152-1154. (doi:10.1093/eurjhf/hfp157)

MacDonald, M.R., Petrie, M.C., Fisher, M., and McMurray, J.J.V. (2009) Pharmacologic management of patients with both heart failure and diabetes. Current Heart Failure Reports, 6(2), pp. 126-132. (doi:10.1007/s11897-009-0019-3)

Stanton, T., Hawkins, N. M., Hogg, K. J., Goodfield, N. E.R., Petrie, M. C., and McMurray, J. J.V. (2009) Three-dimensional echocardiography for optimization of cardiac resynchronization therapy: reply. European Heart Journal, 30(4), pp. 505-506. (doi:10.1093/eurheartj/ehp002)

MacDonald, M.R. et al. (2008) Discordant short- and long-term outcomes associated with diabetes in patients with heart failure: importance of age and sex: a population study of 5.1 million people in Scotland. Circulation: Heart Failure, 1(4), pp. 234-241. (doi:10.1161/CIRCHEARTFAILURE.108.794008)

MacDonald, M.R., Petrie, M.C., Hawkins, N.M., Petrie, J.R., Fisher, M., McKelvie, R., Aguilar, D., Krum, H., and McMurray, J.J.V. (2008) Diabetes, left ventricular systolic dysfunction, and chronic heart failure. European Heart Journal, 29(10), pp. 1224-1240. (doi:10.1093/eurheartj/ehn156)

MacDonald, M.R. et al. (2008) Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. European Heart Journal, 29(11), pp. 1377-1385. (doi:10.1093/eurheartj/ehn153)

Stanton, T., Hawkins, N.M., Hogg, K.J., Goodfield, N.E.R., Petrie, M.C., and McMurray, J.J.V. (2008) How should we optimize cardiac resynchronization therapy? European Heart Journal, 29(20), pp. 2458-2472. (doi:10.1093/eurheartj/ehn380)

Petrie, M. C., and McMurray, J. J.V. (2007) Dysglycemia and heart failure hospitalization: what is the link? Circulation, 115(11), pp. 1334-1335. (doi:10.1161/circulationaha.106.685214) (PMID:17372185)

MacDonald, M. R., Hawkins, N. M., McMurray, J. J.V., Dargie, H. J., and Petrie, M. C. (2006) Is CHARM-added candesartan tolerated in 'real-life” patients with advanced chronic heart failure? Journal of Cardiac Failure, 12(6), S126. (doi:10.1016/j.cardfail.2006.06.434)

Cobbe, S., Martin, W., Motherwell, D., and Petrie, M. (2006) I-123-Metaiodobenzylguanidine in chronic heart failure: is there a clinical use? Nuclear Medicine Communications, 27(12), pp. 927-931. (doi:10.1097/01.mnm.0000251331.48203.74)

Petrie, M. C., McClure, S. J., Love, M. P., and McMurray, J. J.V. (2005) Novel neuropeptides in the pathophysiology of heart failure: adrenomedullin and endothelin-1. European Journal of Heart Failure, 1(1), pp. 25-29. (doi:10.1016/s1388-9842(98)00013-0) (PMID:10937975)

Blue, L. et al. (2001) Randomised controlled trial of specialist nurse intervention in heart failure. British Medical Journal, 323, pp. 715-718. (doi:10.1136/bmj.323.7315.715)

McDonald, J. E., Padmanabhan, N., Petrie, M. C., Hillier, C., Connell, J. M.C., and McMurray, J. J.V. (2001) Vasoconstrictor Effect of the Angiotensin-Converting Enzyme-Resistant, Chymase-Specific Substrate [Pro11D-Ala12] Angiotensin I in Human Dorsal Hand Veins: In Vivo Demonstration of Non-ACE Production of Angiotensin II in Humans. Circulation, 104(15), pp. 1805-1808. (doi:10.1161/hc4001.097220) (PMID:11591618)

Petrie, M., McDonald, J., Hillier, C., Morton, J., and McMurray, J. (2001) Effects of adrenomedullin on angiotensin II stimulated atrial natriuretic peptide and arginine vasopressin secretion in healthy humans. British Journal of Clinical Pharmacology, 52(2), pp. 165-168. (doi:10.1046/j.0306-5251.2001.01428.x)

Petrie, M., Padmanabhan, N., McDonald, J., Hillier, C., Connell, J., and McMurray, J. (2001) Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease. Journal of the American College of Cardiology, 37(4), pp. 1056-1061. (doi:10.1016/S0735-1097(01)01111-1)

Shah, M. R. et al. (2000) Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registry. American Journal of Medicine, 109(6), pp. 489-492. (doi:10.1016/s0002-9343(00)00529-5) (PMID:11042239)

Caruana, L., Petrie, M.C., Davie, A.P., and McMurray, J. (2000) Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study. British Medical Journal, 321, pp. 215-218. (doi:10.1136/bmj.321.7255.215)

Petrie, M. C., Hillier, C., Morton, J., and McMurray, J. J.V. (2000) Adrenomedullin selectively inhibits angiotensin II-induced aldosterone secretion in humans. Journal of Hypertension, 18(1), pp. 61-64. (doi:10.1097/00004872-200018010-00009) (PMID:10678544)

Darnley, G. M., Gray, A. C., McClure, S. J., Neary, P., Petrie, M., McMurray, J. J.V., and MacFarlane, N. G. (1999) Effects of resistive breathing on exercise capacity and diaphragm function in patients with ischaemic heart disease. European Journal of Heart Failure, 1(3), pp. 297-300. (doi:10.1016/s1388-9842(99)00027-6) (PMID:10935679)

Book Sections

MacDonald, M. R., Petrie, M. C., Hawkins, N. M., and McMurray, J. J. (2007) Diabetes, left ventricular systolic dysfunction and chronic heart failure. In: Fisher, M. and McMurray, J. J. (eds.) Diabetic Cardiology. Series: Diabetes in practice. John Wiley & Sons, Ltd.: Chichester, pp. 93-134. ISBN 9780470862049 (doi:10.1002/9780470723807.ch4)

This list was generated on Wed Dec 7 12:20:21 2016 GMT.